CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. REFERENCES 1, , , , , , et al. A decade of RAD51C and RAD51D germline variants in cancer. Hum Mutat. 2022; 43(3): 285–298. 2, , , , , , et al. Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer. PLoS One. 2013; 8(1): e54772. 3, , , , , , et al. Loss of function germline mutations in RAD51D in women with ovarian carcinoma. Gynecol Oncol. 2012; 127(3): 552–555. 4, , , , , , et al.